Table 3 Number of each patient with or without RVO classified based on the office/home blood pressure and the hypertension medication. HTN, hypertension. RVO, retinal vein occlusion. WCH, white coat hypertension. WCUH, white coat uncontrolled hypertension
From: White coat hypertension in acute retinal vein occlusion
|  | HTN medication | RVO (n = 51) | Non-RVO (n = 102) | P value |
|---|---|---|---|---|
Normal office BP | (-) | 14 (27%) | 56 (55%) | Not calculated |
(+) | 11 (22%) | 24 (24%) | Not calculated | |
Total | 25 (49%) | 80 (78%) | Not calculated | |
Sustained HTN/ Uncontrolled HTN | (-) | 5 (10%) | 5 (5%) | 0.04 |
(+) | 5 (10%) | 5 (5%) | 0.28 | |
Total | 10 (20%) | 10 (10%) | 0.02 | |
WCH/ WCUH | (-) | 9 (18%) | 7 (7%) | 0.003 |
(+) | 7 (14%) | 5 (5%) | 0.1 | |
Total | 16 (31%) | 12 (12%) | 0.0007 |